Jazz Pharmaceuticals (JAZZ) Prepaid Assets (2010 - 2026)

Jazz Pharmaceuticals' Prepaid Assets history runs 17 years deep, the most recent figure standing at $285.3 million for Q1 2026.

• In Q1 2026, Prepaid Assets rose 9.81% year-over-year to $285.3 million; the TTM figure through Mar 2026 stood at $285.3 million (up 9.81% YoY), while the FY2025 annual figure was $323.9 million, up 23.84% from the prior year.
• Prepaid Assets was $285.3 million for Q1 2026 at Jazz Pharmaceuticals, down from $323.9 million in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $323.9 million in Q4 2025 to a low of $91.9 million in Q4 2022.
• Historically, Prepaid Assets has averaged $215.0 million across 5 years, with a median of $245.2 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Prepaid Assets slumped 63.58% in 2022, then surged 249.04% in 2023.
• A 5-year view of Prepaid Assets shows it stood at $91.9 million in 2022, then soared by 249.04% to $320.8 million in 2023, then fell by 18.47% to $261.5 million in 2024, then grew by 23.84% to $323.9 million in 2025, then fell by 11.92% to $285.3 million in 2026.
• The last three Prepaid Assets figures came in at $285.3 million (Q1 2026), $323.9 million (Q4 2025), and $315.4 million (Q3 2025), per Business Quant data.